52 Recruiting Metastatic Solid Tumor Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Metastatic Solid Tumor
Related Conditions
Top Recruiting Metastatic Solid Tumor Studies
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
📍 AdventHealth Orlando — Orlando, Florida
View Study & Checklist ➔Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
📍 Miami Cardiac & Vascular Institute — Coral Gables, Florida
View Study & Checklist ➔Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
📍 University of Southern California — Los Angeles, California
View Study & Checklist ➔Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
📍 Alaska Oncology & Hematology, LLC — Anchorage, Alaska
View Study & Checklist ➔QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors
📍 Chan Soon-Shiong Institute for Medicine — El Segundo, California
View Study & Checklist ➔A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
📍 The University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
📍 UCLA — Santa Monica, California
View Study & Checklist ➔Combination Therapy in Cancers With Mutations in DNA Repair Genes
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔